Flossbach Von Storch’s QIAGEN NV QGENF Stock Holding History

Flossbach Von Storch’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-235,000	Closed	-$6.59M	–	103
2016 Q4	$6.59M	Hold	235,000	–	–	0.11%	55
2016 Q3	$6.47M	Buy	235,000 +35,000	+18%	+$964K	0.11%	54
2016 Q2	$4.33M	Sell	200,000 -257,000	-56%	-$5.56M	0.07%	56
2016 Q1	$10.2M	Sell	457,000 -1,000	-0.2%	-$22.3K	0.16%	51
2015 Q4	$12.5M	Sell	458,000 -41,900	-8%	-$1.14M	0.21%	47
2015 Q3	$12.9M	Sell	499,900 -158,600	-24%	-$4.08M	0.22%	46
2015 Q2	$16.2M	Sell	658,500 -38,000	-5%	-$933K	0.31%	44
2015 Q1	$17.5M	Buy	696,500 +45,838	+7%	+$1.15M	0.4%	42
2014 Q4	$15.2M	Sell	650,662 -234,000	-26%	-$5.48M	0.36%	48
2014 Q3	$20.1M	Sell	884,662 -55,000	-6%	-$1.25M	0.44%	42
2014 Q2	$21.8M	Buy	+939,662	New	+$21.8M	0.52%	38

Other funds holding QGENF

BJCM

Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return

Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Flossbach Von Storch's QGENF Position: Q1 2017 in Review

Flossbach Von Storch sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 235,000 shares — an estimated $6.59M sold.

Flossbach Von Storch first reported a position in QGENF in Q2 2014 and held it in 11 quarters. The position peaked at $21.8M in Q2 2014. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

Flossbach Von Storch reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
Flossbach Von Storch sold 235,000 QIAGEN NV shares in Q1 2017, an estimated $6.59M.
Flossbach Von Storch first reported a position in QIAGEN NV in Q2 2014 and held it in 11 quarters.
Flossbach Von Storch's QIAGEN NV position peaked at $21.8M in Q2 2014.
6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Flossbach Von Storch's 13F filing for Q1 2017, filed 4 May 2017.